Overall rank by patents
#26,344
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B60N (SEATS SPECIALLY ADAPTED FOR VEHICLES; VEHICLE PASSENGER ACCOMMODATION NOT OTHERWISE PROVIDED FOR).
The verdict
Freedman holds 10 US patents across 11 technology areas, rank #26,344 of 50,000 tracked assignees.
Freedman Seating Company has been granted 10 US utility patents between 2017 and 2025, placing Freedman Seating Company at rank #26,344 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.0 claims per patent with primary concentration in B60N (SEATS SPECIALLY ADAPTED FOR VEHICLES; VEHICLE PASSENGER ACCOMMODATION NOT OTHERWISE PROVIDED FOR). As a US Corporation, Freedman Seating Company is one of the more focused assignees in the PatentsView dataset. By volume, Freedman sits between Foster Findlay Associates Limited (10 patents, rank #26,340) and Funktion One Research Limited (10 patents, rank #26,348) - the closest US assignees by grant volume. The composite Innovation Score of 38.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 5 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Freedman Seating Company's 14.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Freedman Seating Company against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Foster Findlay Associates Limited
10 patents
Fourds Limited
10 patents
Fourté International, SDN. BHD
10 patents
Fox Chase Cancer Center
10 patents
Freedom Solutions Group, LLC
10 patents
Frequency IP Holdings, LLC
10 patents
Fujita Health University
10 patents
Funktion One Research Limited
10 patents
Freedman Seating Company
10 patents
What this shows Freedman holds 10 patents at rank #26,344, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Freedman's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
38 Top 41% higher than 59% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 20.0% |
| 2018 | 2 | 20.0% |
| 2019 | 1 | 10.0% |
| 2021 | 1 | 10.0% |
| 2022 | 3 | 30.0% |
| 2025 | 1 | 10.0% |
Top 11 of 11 technology areas
Overall rank by patents
#26,344
Across all tracked assignees
38.4 out of 100
How to use this portfolio
Freedman's 10 grants land it in the top 41% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.